Theis KA, Steinweg A, Helmick CG, Courtney-Long E, Bolen JA, Lee R. Which one? What kind? How many? Types, causes, and prevalence of disability among U.S. adults. Disabil Health J. 2019;12(3):411–21.
Theis KA, Murphy LB, Guglielmo D, Boring MA, Okoro CA, Duca LM, et al. Prevalence of arthritis and arthritis-attributable activity limitation - United States, 2016–2018. MMWR Morb Mortal Wkly Rep. 2021;70(40):1401–7.
PubMed PubMed Central Google Scholar
Murphy LB, Cisternas MG, Pasta DJ, Helmick CG, Yelin EH. Medical expenditures and earnings losses among US adults with arthritis in 2013. Arthritis Care Res (Hoboken). 2018;70(6):869–76.
Jamar F, van der Laken CJ, Panagiotidis E, Steinz MM, van der Geest KSM, Graham RNJ, et al. Update on imaging of inflammatory arthritis and related disorders. Semin Nucl Med. 2023;53(2):287–300.
Díaz-González F, Hernández-Hernández MV. Rheumatoid arthritis. Med Clin (Barc). 2023;161(12):533–42.
Gibofsky A. Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis. Am J Manag Care. 2014;20(7 Suppl):S128-135.
McQueen FM. Imaging in early rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2013;27(4):499–522.
Scherer HU, Häupl T, Burmester GR. The etiology of rheumatoid arthritis. J Autoimmun. 2020;110: 102400.
Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet (London, England). 2016;388(10055):2023–38.
Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46(2):183–96.
CAS PubMed PubMed Central Google Scholar
Gravallese EM, Firestein GS. Rheumatoid arthritis - common origins, divergent mechanisms. N Engl J Med. 2023;388(6):529–42.
Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50(2):380–6.
McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205–19.
Akhavani MA, Madden L, Buysschaert I, Sivakumar B, Kang N, Paleolog EM. Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis. Arthritis Res Ther. 2009;11(3):R64.
PubMed PubMed Central Google Scholar
Jang S, Kwon EJ, Lee JJ. Rheumatoid arthritis: pathogenic roles of diverse immune cells. Int J Mol Sci. 2022; Jan 14;23(2):905. https://doi.org/10.3390/ijms23020905.
PubMed PubMed Central Google Scholar
Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med Off Publ, Soc Nucl Med. 1992;33(11):1972–80.
Tahara T, Ichiya Y, Kuwabara Y, Otsuka M, Miyake Y, Gunasekera R, et al. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr. 1989;13(5):829–31.
Sasaki M, Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Fukumura T, et al. Ringlike uptake of [18F]FDG in brain abscess: a PET study. J Comput Assist Tomogr. 1990;14(3):486–7.
Matsui T, Nakata N, Nagai S, Nakatani A, Takahashi M, Momose T, et al. Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in pannus formation in rheumatoid arthritis. J Nucl Med Off Publ, Soc Nucl Med. 2009;50(6):920–6.
Kouijzer IJE, Mulders-Manders CM, Bleeker-Rovers CP, Oyen WJG. Fever of unknown origin: the value of FDG-PET/CT. Semin Nucl Med. 2018;48(2):100–7.
Letertre S, Fesler P, Zerkowski L, Picot MC, Ribstein J, Guilpain P, et al. Place of the (18)F-FDG-PET/CT in the diagnostic workup in patients with classical fever of unknown origin (FUO). J Clin Med. 2021; Augu 26; 10(17):3831.
Wahl RL, Dilsizian V, Palestro CJ. At last, (18)F-FDG for inflammation and infection! J Nucl Med Off Publ, Soc Nucl Med. 2021;62(8):1048–9.
Kubota A, Yamada Y, Kagimoto S, Shimatsu A, Imamura M, Tsuda K, et al. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201–995 in treatment of human endocrine tumors. J Clin Investig. 1994;93(3):1321–5.
CAS PubMed PubMed Central Google Scholar
González-García A, Fabregate M, Serralta G, de Miguel Campo B, Noblejas-Mozo A, Robles-Marhuenda Á. The utility of (18)F-FDG-PET/CT in detecting extracranial large vessel vasculitis in rheumatic polymyalgia or giant cell arteritis. A systematic review and meta-analysis. Revista Clínica Española (English Edition). 2024;224(7):445–56.
Jamar F, Versari A, Galli F, Lecouvet F, Signore A. Molecular imaging of inflammatory arthritis and related disorders. Semin Nucl Med. 2018;48(3):277–90.
Hotta M, Minamimoto R, Kaneko H, Yamashita H. Fluorodeoxyglucose PET/CT of arthritis in rheumatic diseases: a pictorial review. Radiographics. 2020;40(1):223–40.
Beckers C, Ribbens C, André B, Marcelis S, Kaye O, Mathy L, et al. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med Off Publ Soc Nucl Med. 2004;45(6):956–64.
Descamps L, Olagne L, Merlin C, Cachin F, Soubrier M, Mathieu S. Utility of PET/CT in the diagnosis of inflammatory rheumatic diseases: a systematic review and meta-analysis. Ann Rheum Dis. 2018;77(11): e81.
Buchbender C, Ostendorf B, Ruhlmann V, Heusch P, Miese F, Beiderwellen K, et al. Hybrid 18F-labeled fluoride positron emission tomography/magnetic resonance (MR) imaging of the sacroiliac joints and the spine in patients with axial spondyloarthritis: a pilot study exploring the link of MR bone pathologies and increased osteoblastic activity. J Rheumatol. 2015;42(9):1631–7.
Park PSU, Raynor WY, Sun Y, Werner TJ, Rajapakse CS, Alavi A. (18)F-sodium fluoride PET as a diagnostic modality for metabolic, autoimmune, and osteogenic bone disorders: cellular mechanisms and clinical applications. Int J Mol Sci. 2021;22(12):6504. https://doi.org/10.3390/ijms22126504.
Strobel K, Fischer DR, Tamborrini G, Kyburz D, Stumpe KD, Hesselmann RG, et al. 18F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis. Eur J Nucl Med Mol Imaging. 2010;37(9):1760–5.
Son SM, Kim K, Pak K, Kim SJ, Goh TS, Lee JS. Evaluation of the diagnostic performance of (18)F-NaF positron emission tomography/computed tomography in patients with suspected ankylosing spondylitis according to the assessment of spondyloarthritis international society criteria. Spine J. 2020;20(9):1471–9.
Idolazzi L, Salgarello M, Gatti D, Viapiana O, Vantaggiato E, Fassio A, et al. 18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity. Ann Nucl Med. 2016;30(6):430–4.
Hess S, Hansson SH, Pedersen KT, Basu S, Høilund-Carlsen PF. FDG-PET/CT in infectious and inflammatory diseases. PET Clin. 2014;9(4):497–519, vi−vii.
van der Krogt JMA, van Binsbergen WH, van der Laken CJ, Tas SW. Novel positron emission tomography tracers for imaging of rheumatoid arthritis. Autoimmun Rev. 2021;20(3): 102764.
Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, et al. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis. 2005;64(6):834–8.
Tak PP, Smeets TJ, Daha MR, Kluin PM, Meijers KA, Brand R, et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum. 1997;40(2):217–25.
Mulherin D, Fitzgerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 1996;39(1):115–24.
Tak PP, Bresnihan B. The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheum. 2000;43(12):2619–33.
Largeau B, Dupont AC, Guilloteau D, Santiago-Ribeiro MJ, Arlicot N. TSPO PET imaging: from microglial activation to peripheral sterile inflammatory diseases? Contrast Media Mol Imaging. 2017;2017:6592139.
PubMed PubMed Central Google Scholar
Uzuegbunam BC, Rummel C, Librizzi D, Culmsee C, Hooshyar Yousefi B. Radiotracers for imaging of inflammatory biomarkers TSPO and COX-2 in the brain and in the periphery. Int J Mol Sci. 2023; 24(24):17419. https://doi.org/10.3390/ijms242417419.
Gent YY, Voskuyl AE, Kloet RW, van Schaardenburg D, Hoekstra OS, Dijkmans BA, et al. Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study. Arthritis Rheum. 2012;64(1):62–6.
Gent YY, Ter Wee MM, Voskuyl AE, den Uyl D, Ahmadi N, Dowling C, et al. Subclinical synovitis detected by macrophage PET, but not MRI, is related to short-term flare of clinical disease activity in early RA patients: an exploratory study. Arthritis Res Ther. 2015;17:266.
Comments (0)